Reports for BAXTER CORPORATION
Company Name
BAXTER CORPORATION
Totals |
||
Shortage reports |
198 |
|
Actual shortage: | 8 (4%) | |
Anticipated shortage: | 1 (1%) | |
Avoided shortage: | 3 (2%) | |
Resolved: | 186 (94%) | |
Discontinuation Reports |
26 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 26 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
11 (5%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 5G 300MG 900MG | SOLUTION | Resolved | 2017-05-04 | 2017-09-26 | 9057 |
POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 300MG 900MG 5G | SOLUTION | Resolved | 2022-02-25 | 2022-03-26 | 155672 |
POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 300MG 900MG 5G | SOLUTION | Resolved | 2022-08-31 | 2022-11-02 | 168276 |
METRONIDAZOLE INJECTION, USP | 5MG | SOLUTION | Resolved | 2023-12-07 | 2023-12-12 | 212704 |
METRONIDAZOLE INJECTION, USP | 5MG | SOLUTION | Resolved | 2023-12-07 | 2024-02-02 | 212707 |
METRONIDAZOLE INJECTION, USP | 5MG | SOLUTION | Resolved | 2024-02-06 | 2024-02-08 | 218656 |
METRONIDAZOLE INJECTION, USP | 5MG | SOLUTION | Resolved | 2024-02-27 | 2024-03-19 | 220718 |
SODIUM CHLORIDE 3% INJ | 3G | SOLUTION | Resolved | 2022-09-07 | 2022-10-03 | 168709 |
SODIUM CHLORIDE 3% INJ | 3G | SOLUTION | Resolved | 2023-07-06 | 2023-08-15 | 197763 |
TRAVASOL | 730MG 500MG 40MG 680MG 1.15G 1.03G 2.07G 180MG 420MG 480MG 580MG 600MG 580MG 400MG 560MG | SOLUTION | Resolved | 2021-09-07 | 2021-10-02 | 145280 |
TRAVASOL | 730MG 500MG 40MG 680MG 1.15G 1.03G 2.07G 180MG 420MG 480MG 580MG 600MG 580MG 400MG 560MG | SOLUTION | Resolved | 2021-09-23 | 2021-10-02 | 146106 |
TRAVASOL | 730MG 500MG 40MG 680MG 1.15G 1.03G 2.07G 180MG 420MG 480MG 580MG 600MG 580MG 400MG 560MG | SOLUTION | Resolved | 2021-10-13 | 2021-11-05 | 147113 |
DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP | 50MG 3.2MG | SOLUTION | Resolved | 2017-10-12 | 2018-02-07 | 25658 |
DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP | 50MG 3.2MG | SOLUTION | Resolved | 2022-10-04 | 2022-12-01 | 171105 |
DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP | 1.6MG 50MG | SOLUTION | Resolved | 2017-10-11 | 2018-03-07 | 25606 |
DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP | 50MG 1.6MG | SOLUTION | Actual shortage | 2024-05-16 | 2024-05-16 | 228098 |
12% SODIUM CHLORDIE PROCESSING SOLUTION | 12G | SOLUTION | Resolved | 2020-06-22 | 2021-03-24 | 118648 |
1.6% SODIUM CHLORDIE PROCESSING SOLUTION | 1.6G | SOLUTION | Resolved | 2017-07-10 | 2017-12-19 | 15059 |
DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP | .8MG 50MG | SOLUTION | Resolved | 2017-10-12 | 2018-03-07 | 25661 |
DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP | .8MG 50MG | SOLUTION | Resolved | 2020-04-06 | 2020-05-02 | 111045 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120952 |
0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120955 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120958 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120961 |
POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 5G 900MG 300MG | SOLUTION | Discontinued | 2020-11-26 | 2021-02-02 | 128947 |
CLINDAMYCIN INJECTION IN 5% DEXTROSE | 300MG | SOLUTION | Discontinued | 2023-02-06 | 2023-04-02 | 183710 |